Detalhe da pesquisa
1.
YB-1: the Jekyll and Hyde of kidney disease?
Kidney Int
; 105(1): 18-20, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-38182288
2.
Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products-induced inflammation.
Kidney Int
; 105(1): 132-149, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-38069998
3.
Potential of Modulating Aldosterone Signaling and Mineralocorticoid Receptor with microRNAs to Attenuate Diabetic Kidney Disease.
Int J Mol Sci
; 25(2)2024 Jan 10.
Artigo
Inglês
| MEDLINE | ID: mdl-38255942
4.
Targeted deletion of nicotinamide adenine dinucleotide phosphate oxidase 4 from proximal tubules is dispensable for diabetic kidney disease development.
Nephrol Dial Transplant
; 36(6): 988-997, 2021 05 27.
Artigo
Inglês
| MEDLINE | ID: mdl-33367789
5.
Specialized pro-resolving mediators in diabetes: novel therapeutic strategies.
Clin Sci (Lond)
; 133(21): 2121-2141, 2019 11 15.
Artigo
Inglês
| MEDLINE | ID: mdl-31693730
6.
Lipoxins Regulate the Early Growth Response-1 Network and Reverse Diabetic Kidney Disease.
J Am Soc Nephrol
; 29(5): 1437-1448, 2018 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29490938
7.
miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7.
Clin Sci (Lond)
; 129(12): 1237-49, 2015 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-26415649
8.
Study of microRNA in diabetic nephropathy: isolation, quantification and biological function.
Nephrology (Carlton)
; 20(3): 132-9, 2015 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-25487691
9.
Transforming growth factor-ß1-mediated renal fibrosis is dependent on the regulation of transforming growth factor receptor 1 expression by let-7b.
Kidney Int
; 85(2): 352-61, 2014 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-24088962
10.
Where are we in diabetic nephropathy: microRNAs and biomarkers?
Curr Opin Nephrol Hypertens
; 23(1): 80-6, 2014 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-24247820
11.
microRNA in the development of diabetic complications.
Clin Sci (Lond)
; 126(2): 95-110, 2014 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-24059587
12.
Suppression of microRNA-29 expression by TGF-ß1 promotes collagen expression and renal fibrosis.
J Am Soc Nephrol
; 23(2): 252-65, 2012 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-22095944
13.
Ameliorating diabetes-associated atherosclerosis and diabetic nephropathy through modulation of soluble guanylate cyclase.
Front Cardiovasc Med
; 10: 1220095, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37502180
14.
TGF-beta regulates miR-206 and miR-29 to control myogenic differentiation through regulation of HDAC4.
J Biol Chem
; 286(16): 13805-14, 2011 Apr 22.
Artigo
Inglês
| MEDLINE | ID: mdl-21324893
15.
The role of EMT in renal fibrosis.
Cell Tissue Res
; 347(1): 103-16, 2012 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-21845400
16.
What are new avenues for renal protection, in addition to RAAS inhibition?
Curr Hypertens Rep
; 14(2): 100-10, 2012 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-22298106
17.
Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function.
Nat Rev Nephrol
; 17(11): 725-739, 2021 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34282342
18.
Asymmetric Synthesis and Biological Screening of Quinoxaline-Containing Synthetic Lipoxin A4 Mimetics (QNX-sLXms).
J Med Chem
; 64(13): 9193-9216, 2021 07 08.
Artigo
Inglês
| MEDLINE | ID: mdl-34138563
19.
Potential Targeting of Renal Fibrosis in Diabetic Kidney Disease Using MicroRNAs.
Front Pharmacol
; 11: 587689, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-33364960
20.
Therapeutic Potential of Lipoxin A4 in Chronic Inflammation: Focus on Cardiometabolic Disease.
ACS Pharmacol Transl Sci
; 3(1): 43-55, 2020 Feb 14.
Artigo
Inglês
| MEDLINE | ID: mdl-32259087